Immuron

$7.60
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.08 (-1.05%) Today
+$0.05 (+0.66%) As of 11:44 AM UTC after-hours

Why Robinhood?

You can buy or sell Immuron and other stocks, options, and ETFs commission-free!

About IMRN

Immuron Ltd. engages in the research and development of oral immunotherapy, and product sales which focuses on bovine-colostrum with antibodies of choice for the treatment and prevention of a range of infectious and immune modulated diseases. It operates through the following segments: Research and Development, and HyperImmune Products.The Research and Development segment involves the R&D projects performed in Australia, Israel, and United States. The HyperImmune Products segment comprises of Travelan, and Protectyn activities which occur in Australia, United States, and rest of the world. The company was founded on January 13, 1994 and is headquartered in Carlton, Australia. The listed name for IMRN is Immuron Limited American Depositary Shares.

CEO
Jerry Kanellos
Employees
Headquarters
Carlton, Victoria (VIC)
Founded
1994
Market Cap
33.62M
Price-Earnings Ratio
Dividend Yield
Average Volume
541.46K
High Today
$7.72
Low Today
$7.35
Open Price
$7.63
Volume
52.19K
52 Week High
$28.99
52 Week Low
$1.55

Collections

IMRN Earnings

Q1 FY19
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Estimated
per share
Actual
Expected Dec 8, Pre-Market

You May Also Like